Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

被引:0
|
作者
Dario Baratti
Shigeki Kusamura
Daisuke Nonaka
Martin Langer
Salvatore Andreola
Miriam Favaro
Cecilia Gavazzi
Barbara Laterza
Marcello Deraco
机构
[1] National Cancer Institute,Department of Surgery
[2] National Cancer Institute,Department of Pathology
[3] National Cancer Institute,Department of Anesthesiology
[4] National Cancer Institute,Nutritional Care Unit
来源
关键词
Pseudomyxoma peritonei; Peritonectomy; Hyperthermic intraperitoneal chemotherapy; HIPEC; Prognostic factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:526 / 534
页数:8
相关论文
共 50 条
  • [1] Pseudomyxoma peritonei: Clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Baratti, Dario
    Kusamura, Shigeki
    Nonaka, Daisuke
    Langer, Martin
    Andreola, Salvatore
    Favaro, Miriam
    Gavazzi, Cecilia
    Laterza, Barbara
    Deraco, Marcello
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) : 526 - 534
  • [2] Pseudomyxoma peritonei: Clinical, pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
    Baratti, D.
    Nonaka, D.
    Kusamura, S.
    Laterza, B.
    Deraco, M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 64 - 64
  • [3] PSEUDOMYXOMA PERITONEI: PATHOLOGICAL CLASSIFICATION AND CLINICAL OUTCOME OF PATIENTS TREATED BY CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
    Lopes, Andre
    Mello, Evandro S.
    Mendoza Lopez, Rossana Veronica
    Leonardi, Paulo C.
    Ribeiro, Ulysses
    GASTROENTEROLOGY, 2021, 160 (06) : S884 - S885
  • [4] Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Smeenk, Robert M.
    Verwaal, Vic J.
    Antonini, Ninja
    Zoetmulder, Frans A. N.
    ANNALS OF SURGERY, 2007, 245 (01) : 104 - 109
  • [5] Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Iavazzo, Christos
    Spiliotis, John
    UPDATES IN SURGERY, 2020, 72 (03) : 923 - 924
  • [6] Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Christos Iavazzo
    John Spiliotis
    Updates in Surgery, 2020, 72 : 923 - 924
  • [7] Prognostic value of circulating tumor markers in patients with Pseudomyxoma Peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Baratti, Dario
    Kusamura, Shigeki
    Martinetti, Antonia
    Seregni, Ettore
    Laterza, Barbara
    Oliva, Daniela G.
    Deraco, Marcello
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (08) : 2300 - 2308
  • [8] Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Dario Baratti
    Shigeki Kusamura
    Antonia Martinetti
    Ettore Seregni
    Barbara Laterza
    Daniela G. Oliva
    Marcello Deraco
    Annals of Surgical Oncology, 2007, 14 : 2300 - 2308
  • [9] Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience
    Robella, M.
    Vaira, M.
    Marsanic, P.
    Mellano, A.
    Cinquegrana, A.
    Sottile, A.
    De Simone, M.
    MINERVA CHIRURGICA, 2013, 68 (06) : 569 - 577
  • [10] Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
    Scally, Christopher P.
    Fournier, Keith F.
    Mansfield, Paul F.
    JAMA SURGERY, 2021, 156 (03)